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NK cells play a key role in the control of ectromelia virus. In this issue of Immunity, Fang et al. (2011)
demonstrate that the deletion of CD94 abolishes resistance to mousepox infection.Natural killer (NK) cells are key actors in
innate immunity. They protect the host
from many types of viral infections by
sensing proinflammatory cytokines in
their environment as well as changes in
the expression of major histocompati-
bility complex (MHC) class I and other
molecules expressed on the cell surface
during a viral insult. Effector functions of
NK cells are regulated by integrating
signals from their activating and inhibi-
tory receptors. The engagement of inhib-
itory NK cell receptors by MHC class I
molecules expressed by healthy cells
prevents their activation. On the other
hand, NK cells are activated either
through the engagement of their acti-
vating receptors or a lack of engagement
of their inhibitory receptors. Defusing NK
cells is critical for their survival, so over
time viruses have evolved a number of
strategies to evade NK cell control
(Lisnic et al., 2010). Virus-driven evolu-
tion of their natural hosts led to emer-
gence of mechanisms able to oppose
the viral immunoevasion. The best way
to achieve this goal would be selection
of activating NK receptors that specifi-
cally recognize virally infected cells.
Indeed, unlike their inhibitory counter-
parts, many of the activating NK cell
receptors bind to various molecular
determinants of infection and demon-strate certain types of specificity to vir-
ally encoded molecules.
The most studied example of a virus-
specific NK cell response is in C57BL/6
(B6) mice, which are constitutively
resistant to murine cytomegalovirus
(MCMV). These mice express Ly49H, an
activating receptor on their NK cells
that directly interacts with the MCMV
m157 protein, leading to recognition and
elimination of infected cells via cytolytic
mechanisms (Arase et al., 2002). Another
NK cell-dependent mechanism of MCMV
resistance has been described in MA/My
mice, whose activating Ly49P receptor
recognizes the MHC class I allele H2-Dk
bound to a viral protein encoded by the
m04 gene (Kielczewska et al., 2009). It
has to be pointed out that the specificity
of NK cell receptors to virally encoded
molecules is not restricted to herpes
viruses as shown by the fact that
NKp46- and NKp44-activating NK cell
receptors bind to influenza hemagglutinin
(Arnon et al., 2006).
Mousepox or ectromelia virus is
another virus whose pathogenesis is
tightly controlled by NK cells. It belongs
to Orthopoxviruses, a large family of
DNA viruses that includes, in addition to
ectromelia, the variola virus, a causative
agent of smallpox, as well as vaccinia
virus, cowpox virus, and monkeypoxvirus. Unlike several mouse strains that
are highly sensitive to mousepox, B6
mice are able to successfully cope with
mousepox infection without developing
symptoms of the disease. The important
role that NK cells play in the control of
ectromelia infection is best illustrated by
the fact that depletion of NK cells abol-
ishes the resistance of B6 mice to this
virus. In addition to reducing the viral
burden during the early course of infec-
tion, functional NK cells are required for
the generation of an optimal T cell
response (Fang et al., 2008). A dramatic
reduction of both CD8+ and CD4+ T cell
responses is observed in ectromelia-
infected mice depleted of NK cells,
possibly as a consequence of virus-
mediated eradication of dendritic cells.
Although it is well established that NK
cells play a key role in ectromelia virus
infection in B6 mice, the molecular
mechanism of the resistance and the
receptors involved has remained elusive
until now.
In this issue of Immunity, Fang et al.
(2011) explain the mechanism of resis-
tance of B6 mice to ectromelia virus
through the involvement of the CD94
receptor (Figure 1). CD94-NKG2 recep-
tors are composed of an invariant CD94
polypeptide, which forms a heterodimer
with either NKG2A, NKG2C, or NKG2E
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Figure 1. CD94-NKG2E and NKG2D Synergize in Response to Mousepox Virus
Under uninfected conditions, cells express Qa-1b molecules loaded with peptides derived from the signal sequence of MHC class Ia, which engages the
CD94-NKG2A inhibitory receptor. Because CD94-NKG2A dominates over activating CD94-NKG2 receptors, this interaction prevents reactivity of NK cells
against healthy cells. Infection with ectromelia virus induces the expression of activating CD94-NKG2 receptors, which recognize infected cells via Qa-1b
possibly with higher affinity because of expression of viral peptides. NKG2D expression synergizes with CD94-NKG2E, resulting in NK cell activation and
protection against poxvirus. CD94 deficiency prevents the expression of CD94-NKG2E, leading to abolished NK cell activation and subsequent CD8+ T cell
response. This results in loss of resistance to poxvirus. Likewise, Qa-1b deficiency prevents ligation of CD94-NKG2E, which leads to insufficient activation of
NK cells and reduced protection.
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HLA-E molecule in humans and the Qa-1b
molecule in mice as their ligands. These
molecules present peptides derived from
the signal peptide of MHC class Ia mole-
cules that can be substituted with a viral
peptide as part of a viral immune evasion
strategy. Contrary to NKG2A, which is an
inhibitory molecule possessing an immu-
noreceptor tyrosine-based inhibitory
motif (ITIM) in the cytoplasmic domain,
NKG2C and NKG2E possess a charged
amino acid in the transmembrane domain
that allows them to dock to signaling
adaptor protein DAP12, thus eliciting an
activating signal. Because CD94 is
required for transport of NKG2A,
NKG2C, and NKG2E to the cell
membrane, the deletion of CD94
completely prevents the expression of
CD94-NKG2 receptors (Orr et al., 2010).
Interestingly, Klrd1/ mice lacking
the gene encoding CD94 do not differ
from control mice with respect to the
number of NK cells, their maturation,
cytolytic capacity, or the expression
of various markers and recruitment to
draining lymph nodes. Moreover, the
control of various pathogens such as
MCMV, lymphocytic choriomeningitis
virus (LCMV), vaccinia virus, or Listeriamonocytogenes is not altered in Klrd1/
mice (Orr et al., 2011; Fang et al., 2011).
On the contrary, the deletion of CD94
dramatically abolished the resistance of
mice to ectromelia virus (Fang et al.,
2011). This phenomenon was confirmed
by blocking CD94-NKG2 receptors with
antibodies and by the reversion of resis-
tance to ectromelia after the CD94 gene
had been introduced into a Klrd1/
mouse. Furthermore, B6 mice carrying
the natural killer gene complex (NKC)
haplotypes from the mousepox-suscep-
tible DBA/2J strain with a spontaneous
mutation in theKlrd1genearealso suscep-
tible to ectromelia. As one would expect,
mice lacking Qa-1b, a natural ligand for
CD94-NKG2 (Vance et al., 1998, 1999),
also show a markedly reduced ability to
cope with mousepox infection.
What could be the protective principle
in B6 mice infected with ectromelia? The
infection is accompanied by decreased
expression of NKG2A receptors and an
increase in expression of NKG2C and
NKG2E receptors. Yet, contrary to
a dramatic loss of virus control after the
deletion of CD94, mousepox-infected
cells failed to activate reporter cells
expressing CD94 and different isoforms
of NKG2. Based on their previous dataImmunityindicating the role of NKG2D in early
control of ectromelia virus, the authors
proposed that CD94-NKG2 might work
in concert with this activating receptor,
which is otherwise structurally and
functionally different from other NKG2
members and does not pair with CD94.
In order to prove this hypothesis, Fang
et al. (2011) constructed a series of
CD94 reporter cell lines expressing
NKG2C, NKG2E, and a short form of
the NKG2D receptor in all possible
combinations. The results revealed that
only CD94-expressing reporter cells
possessing a combination of NKG2E
and NKG2D could be activated by
ectromelia-infected fibroblasts. Although
the molecular mechanism for the synergy
between the two receptor systems
remains unsolved, the authors speculate
that stimulation through both receptors
is required in order to overcome the inhibi-
tion through NKG2A or other receptors.
Moreover, the engagement of both recep-
tors might favor a stronger activating
signal through the recruitment of DAP12.
Altogether, the work by Fang et al.
(2011) establishes a role for CD94 in the
control of mousepox virus and illustrates
how a limited number of NK cell receptors
can be used in complex ways. This34, April 22, 2011 ª2011 Elsevier Inc. 459
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Previewswork has important implications for our
understanding of natural resistance to
viral disease and as such may lead to
the development of novel approaches
for coping with viral infections. However,
as in the case of all important new find-
ings, the results from this study set the
stage for many new questions that need
to be addressed. As suggested by the
authors, it is likely that the infection results
in the presentation of novel viral or cellular
peptide(s) by Qa-1b because reporter
cells expressing CD94-NKG2E receptors
were not stimulated unless target
cells were infected. Could it be that
Qa-1b-peptide complexes on ectrome-
lia-infected cells exhibit a higher affinity
for CD94-NKG2E? The effect of Qa-1b
deficiency on the mortality rate is much
lower than in Klrd1/ mice, suggesting
the existence of another molecule
involved in CD94-NKG2 signaling. It is
known that CD94 is also expressed on
NKT, gdT cells, and some activated
CD8+ T cells, so it is important to assess
the contribution of these individual cell
subsets in the described phenotype.
Late kinetics of mortality in mice lacking
CD94 suggests that, in addition to NK460 Immunity 34, April 22, 2011 ª2011 Elsevcells, a compromised CD8+ T cell
response might be an immediate cause
of death of mice.
The most puzzling question is the mode
of synergism between NKG2D and CD94-
NKG2E receptors. Is the engagement
of NKG2D by its natural ligands required
to synergize with CD94-NKG2E or does
NKG2D act by stabilizing the CD94-
NKG2E complex by docking next to it?
Alternatively, does CD94-NKG2E act to
stabilize sustained NKG2D expression?
The expansion of CD94-NKG2C has also
been established during HCMV infection,
suggesting the possibility that the involve-
ment of these activating receptors is not
necessarily specific for a single virus
(Guma et al., 2006). Having in mind that
poxviruses share great homology and
the fact that CD94-NKG2 receptors are
well conserved between rodents and
primates, one could speculate that CD94
function might be driven by poxvirus
evolution. Results obtained with the
mousepox virus model indicate that there
is constant pressure for a novel innate
immune response mechanism to resist
viral immunoevasion and virus-induced
pathology.ier Inc.REFERENCES
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In this issue of Immunity, Chaudhry et al. (2011) and Huber et al. (2011) report that control of Th17 cell
responses during colonic inflammation requires direct signaling by IL-10 in regulatory T cells and Th17 cells.Inflammatory responses due to com-
mensal microorganisms or pathological
stimuli are held in check by a variety of
processes involving suppressive cyto-
kines, other soluble mediators, and sup-
pressive populations of inflammatory
cells. The cytokine interleukin-10 (IL-10)
and regulatory T (Treg) cells, such as
FoxP3+ Treg and FoxP3 Tr1 cells, play
both unique and overlapping roles in this
control. IL-10 has regulatory functions
on both innate and adaptive responsesthat are mediated in part by its effects
on antigen-presenting cells, in which it
reduces secretion of proinflammatory
cytokines such as TNF and IL-12 and
lowers expression of costimulatory mole-
cules (Ma and Trinchieri, 2001; Moore
et al., 2001). IL-10 is produced by several
cell types including Treg cells. Treg cells,
on the other hand, regulate immune
responses through multiple mechanisms
including the production of suppressive
cytokines such as IL-10, TGF-b, andIL-35, but also depletion of energy and
growth factors (e.g., ATP and IL-2),
cytolysis of antigen-presenting cells, and
inhibition of antigen-presenting cell
maturation (Vignali et al., 2008). In vitro
assays of Treg cell activity are poor at
modeling their requirements for IL-10.
However, a clear requirement for Treg
cell IL-10 is seen in vivo where it plays
a key role in regulation of inflammation
at environmental interfaces such as the
intestine and the lung. The studies by
